- +963 93 097-2222
- Al Mansoura - Aleppo - Syria
- info@ibn-alhaytham.com
Dual Therapy (Aspirin & Clopidogrel) in Acute Coronary Syndromes – Results from CURE Study
The results of the landmark CURE study, conducted on a broad spectrum of patients with Acute Coronary Syndrome (ACS), have demonstrated that a therapeutic approach based on the dual antiplatelet combination of Aspirin and Clopidogrel provides superior protection compared to Aspirin monotherapy.